Home
Innovent Biologics

Innovent Biologics Market Share Analysis for July 2026

Health > Biotechnology and Pharmaceuticals

Domaininnoventbio.com

Year Founded2011

Employees5001 - 10000

Annual Revenue> $1B

Innovent Biologics

Innovent Biologics (including company regionals)

innoventbio.com

See more website traffic and engagement information

Innovent Biologics Revenue up to July 2026 is > 1B

revenue generated by Innovent Biologics top domains

Innovent Biologics top domains revenue over 3 years

Revenue for Innovent Biologics top domains

innoventbio.com> 1B

See more with Sales Intelligence

Total visits to Innovent Biologics's top domains

Understand Innovent Biologics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

innoventbio.com20.7K

See more with Sales Intelligence

Avg. visit duration in Innovent Biologics's top domains

Analyze Innovent Biologics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

innoventbio.com00:04:45

See more with Sales Intelligence

Avg. pageviews on Innovent Biologics's top domains

See how Innovent Biologics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

innoventbio.com2.76

See more with Sales Intelligence

Innovent Biologics top competitors by domain

Top similar sites in July 2026, ranked by their affinity

replimune.comCompany NameReplimuneEmployees201 - 500HQUnited States, Massachusetts, WoburnAnnual revenue$5M - $10MTotal visits14.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Innovent Biologics

These are the website technologies, by industry, used by Innovent Biologics top domains

Advertising (2)

PubMatic

Audio Video Media (1)

Flowplayer

Conversion & Analytics (1)

Baidu Analytics

Email Services (1)

Microsoft Exchange Online

More Technologies

4

See all

News & Signals from Innovent Biologics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsInnovent Biologics Co. had revenue of $1.22B on Apr 1st '26.Innovent reports over RMB8.2bn in first-half revenue.

NewsAscentage Pharma Group partners with Innovent Biologics.Leveraging its robust R&D capabilities, Ascentage Pharma has built a portfolio of global intellectual property rights and entered into global partnerships and other relationships with numerous leading biotechnology and pharmaceutical companies, such as Takeda, AstraZeneca, Merck, Pfizer, and Innovent, in addition to research and development relationships with leading research institutions, such as Dana-Farber Cancer Institute, Mayo Clinic, National Cancer Institute and the University of Michigan.

NewsInnovent Biologics partnered with Spero Therapeutics, Inc. on Jul 14th '26.Innovent Biologics, a China-based biopharmaceutical company, and Spero Therapeutics, a US-based clinical-stage biopharma company, have entered an for IBI355, a phase 2-ready, 3rd-generation, targeting CD40 ligand (CD40L).